Table 1.
Demographic and clinical characteristics of the patients n (%)
| Characteristics | Number of patients 300 (100) |
| Gender | |
| Male | 177 (59) |
| Female | 123 (41) |
| Age in years | 59.04 (16-86 ) |
| Underlying disease | |
| Immunocompromised | 41 (13.7) |
| Ulcerative colitis | 71 (23.7) |
| One or more bacteria/viruses detected | 215 (71.7) |
| One or more bacteria detected | 146 (48.7) |
| Number of bacteria detected | |
| 1 | 108 (36.0) |
| 2 | 33 (11.0) |
| 3 | 5 (1.67) |
| One or more viruses detected | 148 (49.3) |
| Number of viruses detected | |
| 1 | 96 (32.0) |
| 2 | 45 (15.0) |
| 3 | 7 (2.3) |
| Bacteria detected | |
| Clostridium difficile toxin B | 15 (5.0) |
| Salmonella spp. | 4 (1.3) |
| Campylobacter spp. | 3 (1.0) |
| Vibrio spp. | 1 (0.3) |
| Clostridium perfringens | 36 (12.0) |
| E. coli H7 | 85 (28.3) |
| E. coli O157 | 1 (0.3) |
| VTEC | 1 (0.3) |
| Aeromonas spp. | 43 (14.3) |
| Virus detected | |
| CMV | 37 (12.3) |
| HHV6 | 53 (17.7) |
| EBV | 91 (30.3) |
| HSV1 | 14 (4.7) |
| HSV2 | 6 (2.0) |
| VZV | 6 (2.0) |
E. coli: Escherichia coli; VTEC: Verotoxin-producing E. coli; CMV: Cytomegalovirus; EBV: Epstein-Barr virus; HHV6: Human herpes virus-6; VZV: Varicella zoster virus.